innovative culture but starting to become big pharma - Recensione dipendente - Director presso Regeneron

4,0
2 dic 2022
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

High quality science in most areas, aiming to address diseases where the is great need. Employees are paid and treated well.

Svantaggi

Losing the spirit of a biotech and feeling more like big pharma in some areas. Decision making and hiring often driven by VP-level folks in domains where they lack expertise (instead of the actual scientists). Lots of meetings. Too many managers.

Esplora altre recensioni su Regeneron

5,0
12 mag 2026
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Amazing Work culture as well as Guidance.

Svantaggi

Work as an intern is very repetitive unless trying to expand and work on other project.

3,0
22 giu 2026
Dipendente anonimo
Consiglia
Gradimento del CEO
Pronostico commerciale

Vantaggi

Good pay and benefits. Flexibility of work hours.

Svantaggi

If you're in the wrong group, it's a struggle to get autonomy even when you ask for more oversight of a group or project because micromanaging is an issue. I feel trapped where I am and growth has been stagnant. They also hold a mistake against you for years. Management afraid to give constructive criticism.

Vedi recensioni per: Utile|Valutazione|Data|Tutto